New, better antivirals against COVID-19 are on the way. On Friday, drug giant Merck announced it would seek FDA emergency use approval for a powerful new antiviral, molnupiravir. At least two more such drugs that target the SARS-CoV-2 virus are in the pipeline from other companies, and could save thousandsContinue Reading

MONDAY, Oct. 4, 2021 (HealthDay News) — The United States has now surpassed 700,000 coronavirus deaths, as the highly contagious Delta variant continues to hold the country in its grip. America continues to have more COVID-19 deaths than any other the country in the world, followed by Brazil with moreContinue Reading

MONDAY, Oct. 4, 2021 (HealthDay News) — Black kids and Hispanic kids with cancer fare worse than their white counterparts, a large, nationwide study finds. “This study suggests that improving health insurance coverage and access to care for children, especially those with low [socioeconomic status], may reduce racial/ethnic survival disparities,”Continue Reading

MONDAY, Oct. 4, 2021 (HealthDay News) — Colon cancer numbers dropped dramatically during the COVID-19 pandemic, but that doesn’t mean fewer people have the disease. In Spain, researchers discovered a more than 40% decline in colon cancer diagnoses, leading experts to worry about the ramifications. “These are very worrying findingsContinue Reading

SATURDAY, Oct. 2, 2021 (HealthDay News) — If you work from home and can’t sleep, it may be your circadian rhythms are out of sync, a new study suggests. In short, your sleep-wake cycle may be out of whack, according to Randy Nelson, director of the West Virginia University CenterContinue Reading